HALEY DANIEL: Open Payments
NPI 1205441532 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,811 in 125 payments from 17 companies in 2025. Trend: 2023 $642 · 2024 $1,000 · 2025 $1,811
Food & beverage: $1,811
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 42 | $455 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $331 |
| PFIZER INC. | 10 | $210 |
| Axsome Therapeutics, Inc. | 17 | $202 |
| Alkermes, Inc. | 12 | $177 |
| Lundbeck LLC | 5 | $87 |
| Indivior Inc. | 4 | $85 |
| Otsuka America Pharmaceutical, Inc. | 4 | $74 |
| Tris Pharma Inc | 2 | $36 |
| Novo Nordisk Inc | 2 | $33 |
Products named: CAPLYTA, VRAYLAR, Auvelity, ARISTADA, NURTEC ODT, REXULTI, MAVYRET, SUBLOCADE.
Industry payments across IN — which companies pay providers there.
